Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02073201 · ClinicalTrials.gov registry record
Development of Clinical Methods to Evaluate Neural Function in Aging
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 27
- Enrollment target
NCT02073201 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 27 participants.
The verdict
NCT02073201 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
A primary focus of the University of Florida (UF) Claude D. Pepper Older Americans Independence Center (OAIC) is to build a comprehensive understanding of the causes and consequences of declining physical function and disability development among older adults. To date investigators have largely focused on sarcopenia, the age-related decline in skeletal muscle mass and strength, as the primary contributor to physical decline. However, recent findings indicate that changes in the central and/or peripheral nervous systems may play a larger role than previously thought in the development of functional limitations. These fields hold extensive promise for identifying novel contributors to age-related functional decline. Therefore, the overarching aim of this project is to develop the ability of RC1 to assess novel neural contributors to mobility and overall physical function. Importantly, the development of these techniques will provide the RC1 with the tools to evaluate the potential involvement of the central and peripheral nervous systems in age-related functional decline and disablement. The primary aim of this project is to develop techniques for quantifying peripheral motor unit number and size as well as spinal cord integrity.
Interventions
- OTHER High-functioning older adults
- OTHER Lower-functioning older adults
- OTHER Young adults
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2015-09 |
| Est. Completion | 2017-06-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02073201
The ClinicalTrials.gov registry entry for NCT02073201 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which High-functioning older adults is the first listed.
NCT02073201 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02073201 about?
NCT02073201 is a clinical study titled "Development of Clinical Methods to Evaluate Neural Function in Aging". A primary focus of the University of Florida (UF) Claude D. Pepper Older Americans Independence Center (OAIC) is to build a comprehensive understanding of the causes and consequences of declining physical function and disability development among older adults. To date investigators have largely focu...
What is the current status of trial NCT02073201?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2015-09. Estimated completion is 2017-06-02.
What interventions are being tested in trial NCT02073201?
The interventions under investigation include: High-functioning older adults (OTHER), Lower-functioning older adults (OTHER), Young adults (OTHER).
Who is sponsoring clinical trial NCT02073201?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.